SMAD4 and breast carcinoma: Smad4 is a predictive biomarker of poor prognosis in multiple cancers41–46 and the METABRIC data confirm that alterations in the SMAD4 and SNAI2 genes or their altered expression correlate with lower overall survival in breast cancer.